Johnson & Johnson Showcases TECNIS Odyssey's Innovative Visual Outcomes at ASCRS 2025

Johnson & Johnson Showcases TECNIS Odyssey's Innovative Visual Outcomes at ASCRS 2025



In a thrilling announcement, Johnson & Johnson, a prominent name in eye health, is set to unveil compelling data on their next-generation TECNIS Odyssey Intraocular Lens (IOL) during the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. This event, scheduled from March 25 to 28 in Los Angeles, California, will highlight the latest advancements in ocular technology.

The TECNIS Odyssey has rapidly made a name for itself, being recognized as the fastest growing premium cataract surgery lens in the United States. During the upcoming conference, Johnson & Johnson plans to discuss results from 22 separate abstracts, which encompass clinical research and patient-reported outcomes, signaling significant advancements in retinal care.

Key Findings from Recent Studies


One of the standout features of the TECNIS Odyssey is its ability to provide excellent visual outcomes across all distances—near, intermediate, and far. Studies presented at ASCRS showcase that patients with the TECNIS Odyssey lens report a minimal occurrence of dysphotopsia, a common issue with traditional intraocular lenses, plus a high degree of independence from spectacles post-surgery.

A couple of highlighted studies include:
  • - Patient Reported Outcomes and Visual Acuity After Bilateral Implantation of a Next Generation Presbyopia Correcting Intraocular Lens: This research suggests patients enjoyed remarkable vision improvement at virtually all distances, coupled with high rates of postoperative satisfaction.
  • - Real-World Evidence Visual Outcomes of a Full Visual Range Intraocular Lens: Data indicate a complete visual performance range with virtually no visual complications, emphasizing the lens's efficacy and positive patient experiences.

Support for Ophthalmologists


To support ophthalmologists attending the event, Johnson & Johnson will host educational sessions featuring expert opinions on enhancing patient outcomes using TECNIS Odyssey. Here, distinguished ophthalmologists will provide insights and discuss ways to improve clinical practices. Topics like optimizing the IOL portfolio and delivering complete premium experiences will be featured, aiming to empower surgeons in enhancing their approach to cataract surgery.

Additionally, special events including booth talks and a lunch symposium will take place, allowing attendees to engage directly with their peers and gain invaluable knowledge on the latest techniques and strategies in ocular surgery.

About TECNIS Products


The TECNIS family continues to expand, with the Odyssey lens now supplemented by the findings being discussed at ASCRS. The data not only reinforce TECNIS Odyssey’s superior performance but also provide additional insights on the TECNIS Eyhance and Symfony OptiBlue lenses, known for their efficacy in treating varying degrees of glaucoma. The emphasis lies on delivering versatile solutions that cater to a broader patient demographic, focusing on achieving outstanding vision results.

Johnson & Johnson's Commitment to Eye Health


The commitment of Johnson & Johnson to revolutionize eye care through innovation is evident in their continued investment in research and development. The company continually aims to establish its position as a leader by improving visual health while simultaneously addressing the necessary technological advancements required for successful cataract surgery.

For years, Johnson & Johnson has maintained its mission of enhancing lives through quality healthcare solutions. The strong performance metrics of the TECNIS Odyssey exemplify the promising future of vision correction methodologies that are changing the landscape of cataract surgery.

As patients and professionals alike await the data revealed at ASCRS 2025, the anticipation grows among industry leaders, healthcare professionals, and patients eager for advanced solutions that promise better visual outcomes.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.